Cerecor Stock Price and Value Analysis

Should you buy Cerecor stock? (NasdaqCM:CERC). Let's see how it does in our automated value investing analysis system.

CERC Free Cash Flow Trend

Free Cash Flow trendline for CERC
Free Cash Flow trendline for Cerecor

Hmm, we can't give any reliable projection for Cerecor's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantagesNeutral
None.
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the CERC Numbers

CERC Price
(Cerecor stock price per share)
$3.53
[?] PE Ratio versus Sector 219% higher than other Healthcare stocks
[?] PE Ratio versus Industry 11% higher than other Biotechnology stocks
[?] Free Cash Flow Jitter 42%

Is Cerecor Stock on Sale?

Based on our analysis, we believe that you should not buy Cerecor right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy CERC Stock?

Does Cerecor have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.